I agree the current share price is a buy. However, there are a number of red flags and concerns that remain. For instance, I find it odd that Itronics website still does not list Declan Costelloe nor Duane H. Rasmussen as currently being part of their management team. Why is that? Are they still with the company? Other than the initial press release announcing his joining the company, I have yet to see him quoted in any other press release. Again, I find it odd that the Vice President of Corporate Development since November 2020 has nothing to report. Why is that?
As best as I can tell the company has been around since about 1988. That's roughly 33 years, which is impressive. The issue I have is that they (Dr. Whitney) seems to be on the 500 year plan when it comes to commercializing his discoveries, inventions, processes, whatever you'd like to call them. Certainly by now we should at least be on the OTCBB rather than still being on the pink sheets. Although $3M in sales (from their website) a year is respectable, by now it should be $300M. Dr. Whitney (in my opinion) just can't seem to commercialize what he's got, but is content to forever put his focus on R & D.
Just to clarify, I'm invested here and have been in and out for probably he last ten years, but we seem to just keep going around and around with all kinds of amazing R & D press releases and promises f a new campus and ramped up production. It's time to perform or get off the pot.
